Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HS3ST3B1 mRNA | decreases expression | 20382639
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of HS3ST3B1 mRNA | affects expression | 17484886
|
C051890 |
irinotecan |
irinotecan analog results in increased expression of HS3ST3B1 mRNA | increases expression | 18927307
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of HS3ST3B1 mRNA | increases expression | 17879257
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of HS3ST3B1 mRNA | affects binding|decreases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of HS3ST3B1 mRNA | decreases expression | 17949056
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.38 | 15322242 11752688 14514962 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.92 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.31 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.51 | 17306315 16712894 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.29 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.42 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.40 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.97 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.67 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
4.26 | 16192424 16227642 16050911 15721981 16011737 15673190 16097048 15700767 16124888 10355542 18705752 3786805 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.09 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
3.20 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.20 | 17306315 16507464 15276417 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.46 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.54 | 18670907 18850075 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.52 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
7.52 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.49 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.22 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
2.64 | 17725105 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.36 | 15273666 17159606 16303861 18259882 18509181 16391804 17454858 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.38 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.27 | 15322242 10048152 20055451 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.73 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
4.00 | 19085960 19336974 16227642 3732212 16177239 3786805 9327722 6623471 21278145 15998439 17522070 7179309 10915739 11566570 2869522 7120509 4309450 6884620 7440962 15027814 15968718 10092053 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.00 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
3.02 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.74 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.51 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.37 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.14 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
3.54 | 15959796 61145 12795759 16239168 12631006 17595544 16045604 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.94 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
10.26 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
10.26 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.22 | 16452187 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.21 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.49 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.71 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
4.03 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.37 | 15340226 16120746 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.47 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.66 | 16959395 8697196 18606429 15340226 16354765 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
5.07 | 16899240 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.01 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.57 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.21 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
2.01 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.98 | 20008137 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.98 | 16943688 11408273 11903743 17174718 17334410 16221502 21278145 16239168 17157831 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
2.37 | 15123356 17869086 18279442 15673190 12741479 12666154 18205269 18006644 15996030 18472094 18339082 14748882 12586293 17708605 10355542 15338365 15362042 15931870 17721639 17557913 16027843 18054572 18481824 18472332 17565644 18412020 14716833 14512876 18263696 12632514 18705752 16136751 18429990 15730626 15959796 14716496 11481614 18376398 17976157 17481882 18156304 17761835 17525996 16248980 14724832 17698563 12632512 12898905 12667390 12389079 18187930 17714472 18420326 12445418 18418968 15925388 12609069 16638106 18395095 18251166 13678700 18210741 18317297 17823541 15876570 15818738 16116963 17922224 17631135 15370692 16011737 16015684 17640975 17805973 12445421 12546737 20821823 12649538 16097048 18395914 15057751 18277467 17900296 14620537 15650968 16033810 18166357 15893842 16192424 15052691 12958196 17944888 17766677 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.37 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.15 | 15720792 15830285 16964402 17285989 16246199 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.65 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
4.04 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
8.06 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
8.06 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
8.06 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
6.45 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.45 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.40 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.38 | 16712894 19931552 15276417 17077188 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.38 | 19555203 11884234 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.07 | 16487513 19082730 |
MESH:D052016 |
Mucositis |
|
irinotecan |
5.55 | 17159606 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.31 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.28 | 18259882 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.64 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
4.15 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.65 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.36 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.64 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
5.27 | 8761367 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.52 | 17306315 15276417 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.86 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
4.00 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.73 | 11118676 11222880 11896295 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.24 | 16039940 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.28 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
6.07 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
6.07 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
4.07 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
2.36 | 15723263 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.51 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.62 | 17306315 16452187 16712894 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
4.11 | 11813266 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.96 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.21 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.86 | 15886252 |